Jason Bowling
University of Texas Health Science Center at San Antonio
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jason Bowling.
Antimicrobial Agents and Chemotherapy | 2014
Julius Li; Kelly Echevarria; Darrel W. Hughes; Jose Cadena; Jason Bowling; James S. Lewis
ABSTRACT Contrary to prior case reports that described occasional clinical failures with cefazolin for methicillin-susceptible Staphylococcus aureus (MSSA) infections, recent studies have demonstrated no difference in outcomes between cefazolin and antistaphylococcal penicillins for the treatment of MSSA bacteremia. While promising, these studies described low frequencies of high-inoculum infections, such as endocarditis. This retrospective study compares clinical outcomes of cefazolin versus oxacillin for complicated MSSA bacteremia at two tertiary care hospitals between January 2008 and June 2012. Fifty-nine patients treated with cefazolin and 34 patients treated with oxacillin were included. Osteoarticular (41%) and endovascular (20%) sources were the predominant sites of infection. The rates of clinical cure at the end of therapy were similar between cefazolin and oxacillin (95% versus 88%; P = 0.25), but overall failure at 90 days was higher in the oxacillin arm (47% versus 24%; P = 0.04). Failures were more likely to have received surgical interventions (63% versus 40%; P = 0.05) and to have an osteoarticular source (57% versus 33%; P = 0.04). Failures also had a longer duration of bacteremia (7 versus 3 days; P = 0.0002), which was the only predictor of failure. Antibiotic selection was not predictive of failure. Rates of adverse drug events were higher in the oxacillin arm (30% versus 3%; P = 0.0006), and oxacillin was more frequently discontinued due to adverse drug events (21% versus 3%; P = 0.01). Cefazolin appears similar to oxacillin for the treatment of complicated MSSA bacteremia but with significantly improved safety. The higher rates of failure with oxacillin may have been confounded by other patient factors and warrant further investigation.
Infection Control and Hospital Epidemiology | 2011
Jose Cadena; Teresa Prigmore; Jason Bowling; Beth Ann Ayala; Leni Kirkman; Amruta Parekh; Theresa Scepanski; Jan E. Patterson
For a healthcare worker seasonal influenza vaccination quality improvement project, interventions included support of leadership, distribution of vaccine kits, grand rounds, an influenza website, a screensaver, e-mails, phone messages, and audit feedback. Vaccination rates increased from 58.8% to 76.6% (P < .01). Quality improvement increased the voluntary vaccination rate but did not achieve a rate more than 80%.
Expert Review of Anti-infective Therapy | 2009
Jason Bowling; Elizabeth A. Walter
It is estimated that over 300,000 people with Chagas disease are living in the USA, with more than 30,000 cases of Chagas cardiomyopathy expected per year. The epidemiology of Chagas disease in Central and South America differs from that of the USA, where particular attention must focus on blood bank screening, organ donation and vertical transmission. It is essential that healthcare practitioners have heightened awareness of Chagas disease in the differential diagnosis of certain patients and are aware of recommendations for the management of these patients in the USA. Ongoing attention must focus on trials that determine whether all patients will benefit from treatment as well as studies of new agents for therapy.
Journal of Clinical Microbiology | 2010
Jason Bowling; Aaron E. Owens; M. Leticia McElmeel; Letitia C. Fulcher; Monica L. Herrera; Brian L. Wickes; James H. Jorgensen
ABSTRACT This study assessed an erythromycin-clindamycin (ERY-CC) broth test for inducible CC resistance in beta-hemolytic streptococci. One hundred one isolates of groups A, B, C, F, and G were tested by the CLSI broth microdilution method. Combinations of 1 and 0.25 μg/ml or 0.5 and 0.25 μg/ml of ERY and CC, respectively, detected all inducible isolates.
Infection Control and Hospital Epidemiology | 2015
Daniel J. Morgan; Lisa Pineles; Michelle Shardell; Carol Sulis; Daniel H. Kett; Jason Bowling; Beverly M. Belton; Anthony D. Harris
We report the results of a subgroup analysis of the Benefits of Universal Glove and Gown trial. In 20 intensive care units, the reduction in acquisition of methicillin-resistant Staphylococcus aureus observed in this trial was observed in units also using chlorhexidine bathing and in those that previously performed active surveillance.
Journal of Clinical Microbiology | 2012
Gwen Robinson; Anthony D. Harris; Daniel J. Morgan; Lisa Pineles; Beverly M. Belton; J. Kristie Johnson; Carol Sulis; Connie S. Price; Dan Kett; Dave Warren; David P. Calfee; Deborah S. Yokoe; Deverick J. Anderson; Jason Bowling; Jesse T. Jacob; Joseph Gadbaw; Lisa L. Maragakis; Loreen A. Herwaldt; Marci Drees; Marcus J. Zervos; Matthew E. Lissauer; Nasia Safdar; Robin L. Carver; S. Levine; Syed Shahyrar
ABSTRACT This study determined the survivability of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) for extended periods of time and temperatures using a standard swab for assessment. Our study showed that transportation in Liquid Amies medium could be performed at room temperature or 4°C for up to 14 days without a decrease in recovery of MRSA or VRE.
Open Forum Infectious Diseases | 2017
Jose Cadena; Norys a. Castro-Pena; Heta Javeri; Brian Hernandez; Joel E. Michalek; Ana Fuentes Arzola; Miloni Shroff; Chetan Jinadatha; Gustavo Valero; Jason Bowling; Jean Przykucki; Michele Adams; James H. Jorgensen; Jan E. Patterson; Pranavi Sreeramoju
Abstract Setting Five health care systems in Texas. Objective To describe the epidemiology of inadequate isolation for pulmonary tuberculosis leading to tuberculosis (TB) exposures from confirmed TB patients and the patient factors that led to the exposures. Design A retrospective cohort and case-control study of adult patients with TB resulting in exposures (cases) vs those TB patients who did not result in exposures (controls) during January 2005 to December 2012. Results There were 335 patients with pulmonary TB disease, 199 cases and 136 controls. There was no difference between groups in age (46 ± 14.6 vs 45 ± 17 years; P > .05), race, or substance abuse. Cases were more likely to be transplant recipients (adjusted odds ratio [AOR], 18.90; 95% CI, 1.9–187.76), have typical TB chest radiograph (AOR, 2.23; 95% CI, 1.1–4.51), and have positive acid-fast bacilli stains (AOR, 2.36; 95% CI, 1.31–4.27). Cases were less likely to have extrapulmonary disease (AOR, 0.47; 95% CI, 0.24–0.95). Conclusions TB exposure resulting from inadequate isolation is frequent in health care settings. Extrapulmonary involvement resulted in earlier airborne isolation. Being a transplant recipient, having chest radiograph findings typical for TB, and sputum positivity acid-fast bacilli upon staining were associated with increased risk of inadequate isolation.
Infection Control and Hospital Epidemiology | 2017
Lyndsay M. O'Hara; Daniel J. Morgan; Lisa Pineles; Shanshan Li; Carol Sulis; Jason Bowling; Marci Drees; Jesse T. Jacob; Deverick J. Anderson; David K. Warren; Anthony D. Harris
Quality measures are increasingly reported by hospitals to the Centers for Medicare and Medicaid Services (CMS), yet there may be tradeoffs in performance between infection control (IC) and other quality measures. Hospitals that performed best on IC measures did not perform well on most CMS non-IC quality measures. Infect Control Hosp Epidemiol 2017;38:736-739.
JAMA | 2013
Anthony D. Harris; Lisa Pineles; Beverly M. Belton; J. Kristie Johnson; Michelle Shardell; Mark Loeb; Robin P. Newhouse; Louise M. Dembry; Barbara I. Braun; Eli N. Perencevich; Kendall K. Hall; Daniel J. Morgan; Syed K. Shahryar; Connie S. Price; Joseph Gadbaw; Marci Drees; Daniel H. Kett; L. Silvia Munoz-Price; Jesse T. Jacob; Loreen A. Herwaldt; Carol Sulis; Deborah S. Yokoe; Lisa L. Maragakis; Matthew E. Lissauer; Marcus J. Zervos; David K. Warren; Robin L. Carver; Deverick J. Anderson; David P. Calfee; Jason Bowling
Clinical Infectious Diseases | 2012
Daniel J. Morgan; Jennifer Meddings; Sanjay Saint; Ebbing Lautenbach; Michelle Shardell; Deverick J. Anderson; Aaron M. Milstone; Marci Drees; Lisa Pineles; Nasia Safdar; Jason Bowling; David C. Henderson; Deborah S. Yokoe; Anthony D. Harris
Collaboration
Dive into the Jason Bowling's collaboration.
University of Texas Health Science Center at San Antonio
View shared research outputs